|
TTC33 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.10410022738472E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63089985960596E-10 |
| Normal-vs-Stage2 |
1.799710E-04 |
| Normal-vs-Stage3 |
2.757200E-04 |
| Normal-vs-Stage4 |
1.408080E-04 |
| Stage1-vs-Stage2 |
4.603000E-01 |
| Stage1-vs-Stage3 |
6.557400E-01 |
| Stage1-vs-Stage4 |
9.183000E-01 |
| Stage2-vs-Stage3 |
7.744800E-01 |
| Stage2-vs-Stage4 |
6.497200E-01 |
| Stage3-vs-Stage4 |
8.619800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.35439487087319E-11 |
| Normal-vs-AfricanAmerican |
1.81259999998407E-06 |
| Normal-vs-Asian |
1.483350E-03 |
| Caucasian-vs-AfricanAmerican |
3.560600E-01 |
| Caucasian-vs-Asian |
9.640000E-01 |
| AfricanAmerican-vs-Asian |
7.887400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.82359682909805E-11 |
| Normal-vs-Female |
7.72110000000215E-05 |
| Male-vs-Female |
3.010400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.33349999825927E-08 |
| Normal-vs-Extreme_Weight |
1.19569998346947E-09 |
| Normal-vs-Obese |
1.69260000004723E-06 |
| Normal-vs-Extreme_Obese |
1.60932999999641E-05 |
| Normal_Weight-vs-Extreme_Weight |
7.392400E-01 |
| Normal_Weight-vs-Obese |
1.831850E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.302200E-01 |
| Extreme_Weight-vs-Obese |
2.431400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.867400E-01 |
| Obese-vs-Extreme_Obese |
3.149600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.443140E-04 |
| Normal-vs-Age(41-60Yrs) |
2.01300000002291E-06 |
| Normal-vs-Age(61-80Yrs) |
6.07625061377348E-13 |
| Normal-vs-Age(81-100Yrs) |
1.78711999999637E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.009000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.091420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.544200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.962800E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.528800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.824800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.06390005086377E-09 |
| Normal-VS-Type2 PRCC |
2.62769805914331E-11 |
| Normal-VS-KIRP CIMP |
1.63949999998358E-06 |
| Normal-VS-Unclassified PRCC |
6.235900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.088100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.633600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.273400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.412400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.227700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.102150E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.60389998241584E-09 |
| Normal-vs-N1 |
1.425240E-04 |
| Normal-vs-N2 |
2.464600E-03 |
| N0-vs-N1 |
5.497000E-01 |
| N0-vs-N2 |
9.814200E-01 |
| N1-vs-N2 |
7.963200E-01 |
|
|
